#50 What The July FDA Hearing Could Mean For Compounded Peptides
The internet loves a scary headline, and “peptides placed in category two” might be the most misunderstood one yet. We’re Dr. Kylie Burton and Jessica Briecke, and we’re slowing the noise down to explain what’s actually happening with the FDA’s July 23–24 hearing and why it directly affects patient access to compounded peptides. It started back in 2023 when compounding pharmacies pushed back against government regulation. What happened then and what's happening now revolves around the FDA's ...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Peptalk: Peptides Unpacked
BONUS: You Don't Have to Be an Expert — Tanya Proves Anyone Can Do This
BONUS: How A Second Home Became Possible Without More Office Hours
#49 Peptides Cause Cancer? Jen's Oncologist Was the One Who Recommended Them.
#48 Migraines for 35 Years — Gone for Now 7 Months. What Finally Gave Amy Relief?
Get summaries like this every morning.
Free AI-powered recaps of Peptalk: Peptides Unpacked and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.